Early research (Phase 1)Study completedNCT04774952What this trial is testingDose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid TumorsWho this might be right forSolid Tumors Revolution Medicines, Inc. 58
Testing effectiveness (Phase 2)Looking for participantsNCT07749586What this trial is testingEvaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor Arvinas Inc. 499
Early research (Phase 1)Looking for participantsNCT07589205What this trial is testingStudy of IBI3028 in Participants With Locally Advanced, Unresectable, or Metastatic Solid TumorsWho this might be right forSolid TumorColorectal CancerNon-small Cell Lung Cancer+2 more Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. 493
Early research (Phase 1)Study completedNCT03518554What this trial is testingA First in Human, Dose Escalation Study of JAB-3068 （SHP2 Inhibitor） in Adult Patients With Advanced Solid TumorsWho this might be right forNon-small Cell Lung CancerHead and Neck CancerEsophageal Cancer+1 more Jacobio Pharmaceuticals Co., Ltd. 38
Early research (Phase 1)Study completedNCT02955251What this trial is testingABBV-428, an Immunotherapy, in Subjects With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Cancer AbbVie 61
Testing effectiveness (Phase 2)UnknownNCT05505877What this trial is testingPhase I/IIa Study of BR790 in Combination With Tislelizumab in Adult Subjects With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor Shanghai Gopherwood Biotech Co., Ltd. 160
Early research (Phase 1)Study completedNCT05479812What this trial is testingDose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid TumorsWho this might be right forMetastatic Solid TumorAdvanced Solid Tumor Werewolf Therapeutics, Inc. 156
Early research (Phase 1)Study completedNCT00031681What this trial is testing7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)Who this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more National Cancer Institute (NCI) 41
Early research (Phase 1)UnknownNCT05360381What this trial is testingHLX35(EGFR×4-1BB Bispecific) in Patients With Advanced or Metastatic Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid TumorsSquamous-cell Non-small Cell Lung Cancer Shanghai Henlius Biotech 82
Early research (Phase 1)Looking for participantsNCT06789172What this trial is testingA Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid TumorsWho this might be right forSolid TumoursSarcomaHNSCC+12 more Epkin 146
Testing effectiveness (Phase 2)Looking for participantsNCT06799065What this trial is testingFirst-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian CancerWho this might be right forAdvanced Solid TumorsBreast Cancer RecurrentOvarian Cancer+4 more Accent Therapeutics 218
Early research (Phase 1)Study completedNCT04943900What this trial is testingBMS-986416 With and Without Nivolumab in Select Solid TumorsWho this might be right forAdvanced Solid Tumors Bristol-Myers Squibb 67
Early research (Phase 1)Study completedNCT03689192What this trial is testingArginase-1 Peptide Vaccine in Patients With Metastatic Solid TumorsWho this might be right forNon Small Cell Lung CancerUrothelial CarcinomaMalignant Melanoma+5 more Herlev Hospital 13